Placebo and the new physiology of the doctor-patient relationship.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMC 3962549)

Published in Physiol Rev on July 01, 2013

Authors

Fabrizio Benedetti1

Author Affiliations

1: Department of Neuroscience, University of Turin Medical School, and National Institute of Neuroscience, Turin, Italy. fabrizio.benedetti@unito.it

Articles citing this

Genetics and the placebo effect: the placebome. Trends Mol Med (2015) 0.94

Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures. Neuropsychopharmacology (2014) 0.94

Harnessing the placebo effect in pediatric migraine clinic. J Pediatr (2014) 0.92

The placebo effect: From concepts to genes. Neuroscience (2015) 0.91

Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression. Psychol Bull (2014) 0.90

Teaching neurons to respond to placebos. J Physiol (2016) 0.89

How Health Professionals Conceptualize and Represent Placebo Treatment in Clinical Trials and How Their Patients Understand It: Impact on Validity of Informed Consent. PLoS One (2016) 0.82

Exploring the dimensions of doctor-patient relationship in clinical practice in hospital settings. Int J Health Policy Manag (2014) 0.82

Understanding placebo and nocebo responses for pain management. Curr Pain Headache Rep (2014) 0.81

Social Bonds and Exercise: Evidence for a Reciprocal Relationship. PLoS One (2015) 0.79

Trust in the health care professional and health outcome: A meta-analysis. PLoS One (2017) 0.79

Understanding the non-pharmacological correlates of self-reported efficacy of antidepressants. Acta Psychiatr Scand (2015) 0.77

Inverted Perceptual Judgment of Nociceptive Stimuli at Threshold Level following Inconsistent Cues. PLoS One (2015) 0.76

Placebo Response is Driven by UCS Revaluation: Evidence, Neurophysiological Consequences and a Quantitative Model. Sci Rep (2016) 0.76

Use acupuncture to relieve perimenopausal syndrome: study protocol of a randomized controlled trial. Trials (2014) 0.76

Different Placebos, Different Mechanisms, Different Outcomes: Lessons for Clinical Trials. PLoS One (2015) 0.76

The paradox of sham therapy and placebo effect in osteopathy: A systematic review. Medicine (Baltimore) (2016) 0.75

Paraspinous Lidocaine Injection for Chronic Nonspecific Low Back Pain: A Randomized Controlled Clinical Trial. J Pain (2016) 0.75

Assessing subjective quality of life domains after multiple sclerosis diagnosis disclosure. Health Expect (2015) 0.75

Pain and placebo in pediatrics: a comprehensive review of laboratory and clinical findings. Pain (2014) 0.75

Nocebo hyperalgesia: contributions of social observation and body-related cognitive styles. J Pain Res (2016) 0.75

The hardest thing to see is what is in front of your eyes - quo vadis placebo analgesia? J Pain Res (2016) 0.75

Nasal Dilator Strip is an Effective Placebo Intervention for Severe Obstructive Sleep Apnea. J Clin Sleep Med (2016) 0.75

Efficacy and Safety of Injectable Robenacoxib for the Treatment of Pain Associated With Soft Tissue Surgery in Dogs. J Vet Intern Med (2017) 0.75

Placebo by Proxy in Neonatal Randomized Controlled Trials: Does It Matter? Children (Basel) (2017) 0.75

Efficacy of individualised diets in patients with irritable bowel syndrome: a randomised controlled trial. BMJ Open Gastroenterol (2017) 0.75

[Placebo and nocebo : How can they be used or avoided?] Internist (Berl) (2017) 0.75

Expectations do not Influence the Response to Phosphosdiesterase Type 5 Inhibitor Therapy for Erectile Dysfunction. Pharmacy (Basel) (2015) 0.75

Effect of acupuncture and its influence on cerebral activity in perimenopausal insomniacs: study protocol for a randomized controlled trial. Trials (2017) 0.75

Articles cited by this

(truncated to the top 100)

An integrative theory of prefrontal cortex function. Annu Rev Neurosci (2001) 36.82

The fusiform face area: a module in human extrastriate cortex specialized for face perception. J Neurosci (1997) 22.73

The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev (1993) 19.60

Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci (1986) 18.17

The mirror-neuron system. Annu Rev Neurosci (2004) 17.46

Oxytocin increases trust in humans. Nature (2005) 13.70

Empathy for pain involves the affective but not sensory components of pain. Science (2004) 11.33

Influence of context effects on health outcomes: a systematic review. Lancet (2001) 10.12

Getting formal with dopamine and reward. Neuron (2002) 9.83

The chameleon effect: the perception-behavior link and social interaction. J Pers Soc Psychol (1999) 8.42

Placebo-induced changes in FMRI in the anticipation and experience of pain. Science (2004) 8.33

The powerful placebo. J Am Med Assoc (1955) 8.30

Placebo response in studies of major depression: variable, substantial, and growing. JAMA (2002) 7.56

Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry (2000) 7.31

Language within our grasp. Trends Neurosci (1998) 7.25

Development and neurophysiology of mentalizing. Philos Trans R Soc Lond B Biol Sci (2003) 7.15

Dynamics of gray matter loss in Alzheimer's disease. J Neurosci (2003) 7.03

Interacting minds--a biological basis. Science (1999) 6.41

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol (2003) 6.21

Empathic neural responses are modulated by the perceived fairness of others. Nature (2006) 6.04

The eyes have it: the neuroethology, function and evolution of social gaze. Neurosci Biobehav Rev (2000) 6.03

Nonspecific medication side effects and the nocebo phenomenon. JAMA (2002) 5.79

Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron (2008) 5.61

Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature (1994) 5.55

Learned helplessness in humans: critique and reformulation. J Abnorm Psychol (1978) 5.40

Biological, clinical, and ethical advances of placebo effects. Lancet (2010) 5.36

Dissociation in prefrontal cortex of affective and attentional shifts. Nature (1996) 5.30

Automatic and intentional brain responses during evaluation of trustworthiness of faces. Nat Neurosci (2002) 5.29

Putting the altruism back into altruism: the evolution of empathy. Annu Rev Psychol (2008) 5.29

The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat (2003) 5.16

The human amygdala in social judgment. Nature (1998) 5.03

Psychological and neural mechanisms of the affective dimension of pain. Science (2000) 4.98

Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry (2003) 4.94

The neural basis of mentalizing. Neuron (2006) 4.86

The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Brain Res Rev (1999) 4.77

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med (1998) 4.72

Active albuterol or placebo, sham acupuncture, or no intervention in asthma. N Engl J Med (2011) 4.68

First impressions: making up your mind after a 100-ms exposure to a face. Psychol Sci (2006) 4.68

The functional architecture of human empathy. Behav Cogn Neurosci Rev (2004) 4.68

Placebo and opioid analgesia-- imaging a shared neuronal network. Science (2002) 4.57

Oxytocin improves "mind-reading" in humans. Biol Psychiatry (2006) 4.56

Functional magnetic resonance imaging of reward prediction. Curr Opin Neurol (2005) 4.53

Pavlovian conditioning. It's not what you think it is. Am Psychol (1988) 4.45

A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol (2008) 4.43

Etiopathogenesis of murine SLE. Immunol Rev (1981) 4.39

Dissociating pain from its anticipation in the human brain. Science (1999) 4.36

Neurobiology of suicidal behaviour. Nat Rev Neurosci (2003) 4.25

The mechanism of placebo analgesia. Lancet (1978) 4.10

Uniquely human social cognition. Curr Opin Neurobiol (2006) 4.03

Placebo effects mediated by endogenous opioid activity on mu-opioid receptors. J Neurosci (2005) 4.00

Intentional ignorance: a history of blind assessment and placebo controls in medicine. Bull Hist Med (1998) 3.96

Patients' trust in physicians: many theories, few measures, and little data. J Gen Intern Med (2000) 3.77

Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb Cortex (2000) 3.75

Patient-physician trust: an exploratory study. J Fam Pract (1997) 3.63

Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Arch Gen Psychiatry (2008) 3.47

The legitimacy of placebo treatments in clinical practice: evidence and ethics. Am J Bioeth (2009) 3.46

The placebo effect: dissolving the expectancy versus conditioning debate. Psychol Bull (2004) 3.45

The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol (1994) 3.42

Neurobiological mechanisms of the placebo effect. J Neurosci (2005) 3.41

Placebo effects on human mu-opioid activity during pain. Proc Natl Acad Sci U S A (2007) 3.33

Deconstructing the placebo effect and finding the meaning response. Ann Intern Med (2002) 3.31

Response variability to analgesics: a role for non-specific activation of endogenous opioids. Pain (2001) 3.26

The functional neuroanatomy of the placebo effect. Am J Psychiatry (2002) 3.26

Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci (2006) 3.25

Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems. J Neurosci (1999) 3.19

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science (2001) 3.18

Nocebo phenomena in medicine: their relevance in everyday clinical practice. Dtsch Arztebl Int (2012) 3.16

Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol Psychiatry (2008) 3.13

Individual differences in reward responding explain placebo-induced expectations and effects. Neuron (2007) 2.96

Classical conditioning and the placebo effect. Pain (1997) 2.95

Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science (2005) 2.91

Placebo in emotional processing--induced expectations of anxiety relief activate a generalized modulatory network. Neuron (2005) 2.90

The subjective experience of pain: where expectations become reality. Proc Natl Acad Sci U S A (2005) 2.84

Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol (2004) 2.73

Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting. Soc Cogn Affect Neurosci (2008) 2.72

Control of pain in adults with cancer: summary of SIGN guidelines. BMJ (2008) 2.72

Two systems for empathy: a double dissociation between emotional and cognitive empathy in inferior frontal gyrus versus ventromedial prefrontal lesions. Brain (2008) 2.70

The eye contact effect: mechanisms and development. Trends Cogn Sci (2009) 2.69

New insights into the placebo and nocebo responses. Neuron (2008) 2.64

A touching sight: SII/PV activation during the observation and experience of touch. Neuron (2004) 2.63

Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci (2003) 2.62

Empathy for positive and negative emotions in the gustatory cortex. Neuroimage (2006) 2.61

Lending a hand: social regulation of the neural response to threat. Psychol Sci (2006) 2.61

The social role of touch in humans and primates: behavioural function and neurobiological mechanisms. Neurosci Biobehav Rev (2008) 2.57

Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron (2009) 2.55

An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain (1999) 2.51

Placebo response in depression: bane of research, boon to therapy. Br J Psychiatry (2001) 2.46

The role of conditioning and verbal expectancy in the placebo response. Pain (1990) 2.41

Mobile phone headache: a double blind, sham-controlled provocation study. Cephalalgia (2007) 2.40

Changes in brain function of depressed subjects during treatment with placebo. Am J Psychiatry (2002) 2.39

The human amygdala plays an important role in gaze monitoring. A PET study. Brain (1999) 2.33

Mechanisms of face perception. Annu Rev Neurosci (2008) 2.30

Facial expression of pain: an evolutionary account. Behav Brain Sci (2002) 2.30

Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain (2005) 2.26

Implicit trustworthiness decisions: automatic coding of face properties in the human amygdala. J Cogn Neurosci (2007) 2.26

The powerful placebo effect: fact or fiction? J Clin Epidemiol (1997) 2.23

The effect of treatment expectation on drug efficacy: imaging the analgesic benefit of the opioid remifentanil. Sci Transl Med (2011) 2.19

Placebo analgesia induced by social observational learning. Pain (2009) 2.18

How prior experience shapes placebo analgesia. Pain (2006) 2.15

Does anticipation of pain affect cortical nociceptive systems? J Neurosci (2002) 2.15

Articles by these authors

Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol (2008) 2.11